GeneMedi was founded in 2018 by a team of interdisciplinary experts in drug discovery, CMC process development, computational biology, and materials chemistry. GeneMedi is dedicated to empowering cell and gene therapy (CGT) development through high-efficiency purification and rigorous quality control solutions.